---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-24-050397"
form_type: "8-K/A"
ticker: null
cik: "0001839998"
company_name: "American Oncology Network, Inc."
filed_at: "2024-12-26T23:59:59+00:00"
generated_at: "2026-05-28T23:22:31.944189+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# American Oncology Network completes acquisition of Central Georgia Cancer Care for ~$13.3M

## Summary
- Acquisition of CGCC assets for $4.6M cash, $6.4M promissory note (60-month term), and ~$2.3M for inventories.
- CGCC had $102.7M patient revenue in 2023, net loss of $1.03M, and total assets of $18.6M.
- $6.4M note requires monthly payments of $106,667 plus interest at AON's variable borrowing cost.
- CGCC operates two oncology practice locations in Macon and Warner Robins, Georgia.
- Amendment corrects omitted date in audit report; no change to prior disclosure.

## SEC filing metadata
- accession: 0001140361-24-050397
- form_type: 8-K/A
- cik: 0001839998
- company_name: American Oncology Network, Inc.
- filed_at: 2024-12-26T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1839998/000114036124050397/0001140361-24-050397-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1839998/000114036124050397/ef20040705_8ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-24-050397
- JSON: https://secwatch.observer/filing/0001140361-24-050397.json
- Plain text: https://secwatch.observer/filing/0001140361-24-050397.txt

## Key facts
- M&A Transactions
  American Oncology Network, Inc. completed an acquisition involving Central Georgia Cancer Care, P.C. shareholders for $4.6 million cash, $6.4 million promissory note, and approximately $2.3 million cash for inventories (closed 2024-04-01).
  - Action: acquisition
  - Counterparty: Central Georgia Cancer Care, P.C. shareholders
  - Consideration: $4.6 million cash, $6.4 million promissory note, and approximately $2.3 million cash for inventories
  - Closing: 2024-04-01
  source text: On April 1, 2024, consolidated subsidiaries of American Oncology Network, Inc. (“AON” or the “Company”) acquired certain clinical and non-clinical assets of Central Georgia Cancer Care, P.C., (“CGCC”) from the CGCC shareholders for consideration consisting of (i) a cash payment in the amount of $4.6 million, (ii) a promissory note in the amount of $6.4 million under which the terms require principal and interest payments in monthly installments over 60 months commencing May 1, 2024, and (iii) a cash payment of approximately $2.3 million for acquired inventories, (the “CGCC Acquisition”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1839998/000114036124050397/0001140361-24-050397-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.